Cargando…

B-Cell-Based Immunotherapy: A Promising New Alternative

The field of immunotherapy has undergone radical conceptual changes over the last decade. There are various examples of immunotherapy, including the use of monoclonal antibodies, cancer vaccines, tumor-infecting viruses, cytokines, adjuvants, and autologous T cells carrying chimeric antigen receptor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Sneh Lata, Khan, Naeem, Basu, Srijani, Soni, Vijay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227543/ https://www.ncbi.nlm.nih.gov/pubmed/35746487 http://dx.doi.org/10.3390/vaccines10060879

Ejemplares similares

Immunotherapy: an alternative promising therapeutic approach against cancers
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Role of Immunoglobulin A in COVID-19 and Influenza Infections
por: Tyagi, Rohit, et al.
Publicado: (2023)

IgA Determines Bacterial Composition in the Gut
por: Gupta, Suman, et al.
Publicado: (2023)

Neutralizing antibody: a savior in the Covid-19 disease
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Promise and Challenges of T Cell Immunotherapy for Osteosarcoma
por: Park, Jeong A, et al.
Publicado: (2023)

Neoadjuvant Immunotherapy: A Promising New Standard of Care
por: Boydell, Emma, et al.
Publicado: (2023)

CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
por: Hadiloo, Kaveh, et al.
Publicado: (2023)

Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma
por: Cho, Shih-Feng, et al.
Publicado: (2021)

CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks
por: Hovhannisyan, Lusine, et al.
Publicado: (2023)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

Natural killer cells: a promising immunotherapy for cancer
por: Chu, Junfeng, et al.
Publicado: (2022)

The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
por: Legut, Mateusz, et al.
Publicado: (2015)

Immunotherapy for glioblastoma: the promise of combination strategies
por: Bausart, Mathilde, et al.
Publicado: (2022)

Immunotherapy of Multiple Myeloma: Promise and Challenges
por: Abramson, Hanley N
Publicado: (2021)

Exosome-based immunotherapy: a promising approach for cancer treatment
por: Xu, Zhijie, et al.
Publicado: (2020)

Adoptive Cell Transfer: Is it a Promising Immunotherapy for Colorectal Cancer?
por: Fan, Jiaqiao, et al.
Publicado: (2018)

CAR-NK cells: A promising cellular immunotherapy for cancer
por: Xie, Guozhu, et al.
Publicado: (2020)

Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
por: Ma, Tiantian, et al.
Publicado: (2019)

Nanomaterials as Promising Alternative in the Infection Treatment
por: Vallet-Regí, María, et al.
Publicado: (2019)

NK cell-based immunotherapy for treating cancer: will it be promising?
por: Cho, Duck, et al.
Publicado: (2011)

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
por: Hendrickson, Peter G., et al.
Publicado: (2019)

VISTA: A Promising Target for Cancer Immunotherapy?
por: Tagliamento, Marco, et al.
Publicado: (2021)

Lung cancer immunotherapy: progress, pitfalls, and promises
por: Lahiri, Aritraa, et al.
Publicado: (2023)

The Terpene Mini-Path, a New Promising Alternative for Terpenoids Bio-Production
por: Couillaud, Julie, et al.
Publicado: (2021)

Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

An Assessment of the Bivalent Vaccine as a Second Booster for COVID-19
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Role of B7 family members in glioma: Promising new targets for tumor immunotherapy
por: Wang, Yan, et al.
Publicado: (2023)

The Significance of Lipids to Biofilm Formation in Candida albicans: An Emerging Perspective
por: Alim, Darakshan, et al.
Publicado: (2018)

CAR‐NK cell in cancer immunotherapy; A promising frontier
por: Marofi, Faroogh, et al.
Publicado: (2021)

Local γδ T cells: translating promise to practice in cancer immunotherapy
por: Zlatareva, Iva, et al.
Publicado: (2023)

Aptamer-Based Analysis: A Promising Alternative for Food Safety Control
por: Amaya-González, Sonia, et al.
Publicado: (2013)

Microalgal-based feed: promising alternative feedstocks for livestock and poultry production
por: Saadaoui, Imen, et al.
Publicado: (2021)

Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
por: Chasov, Vitaly, et al.
Publicado: (2021)

Talquetamab: A promising immunotherapy for multiple myeloma
por: Tariq, Amna, et al.
Publicado: (2023)

TIM-3, a promising target for cancer immunotherapy
por: He, Yayi, et al.
Publicado: (2018)

The clinical promise of immunotherapy in triple-negative breast cancer
por: Vikas, Praveen, et al.
Publicado: (2018)

Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma
por: Biteghe, Fleury Augustin Nsole, et al.
Publicado: (2020)

Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy
por: Gosmann, Dario, et al.
Publicado: (2022)

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges
por: Pavan, A., et al.
Publicado: (2019)

Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy
por: Fucà, G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9orf4r7lb55to5jqif7d0q1get